Abstract
The role and type of adjuvant therapy in endometrial cancer remains controversial; the benefits of any adjuvant treatment must be weighed against potential toxicities. Thus, our objective was to determine the acute toxicity of adjuvant intensity modulated radiation therapy (IMRT) with and without adjuvant combination chemotherapy in patients with endometrial cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
